Service & Suppliers

Found 26,936 articles

• XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and development, opening a new paradigm for scientific innovation

  11/25/2022

  XtalPi announced that they are embarking on a strategic collaboration with CK Life Sciences, a member of the CK Hutchison Group.

• CHUV, CERN and THERYQ join forces for a world first in cancer radiotherapy

  11/25/2022

  The Centre Hospitalier Universitaire Vaudois in Lausanne, Switzerland, the European Laboratory for Particle Physics and THERYQ have signed an agreement for the world-first development of a revolutionary FLASH radiotherapy device that will use very high energy electron radiation to treat cancers resistant to conventional treatments.

• Revive Therapeutics Announces Update for Type C Meeting to Discuss Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

  11/24/2022

  Revive Therapeutics Ltd. announced that it will submit the Type C meeting request package to the US FDA by mid-December 2022, which will outline the overall development plan and Pre-Dose selection data supporting the latest revised endpoints for the Company’s Phase 3 clinical trial to evaluate the safety and efficacy of Bucillamine, an oral drug with anti-inflammatory and antiviral properties, in patients with mild to moderate COVID-19.

• Inspira™ Technologies Reports Third Quarter 2022 Financial Results

  11/23/2022

  Inspira Technologies OXY B.H.N. Ltd., a groundbreaking respiratory support technology company, announced its financial results for the third quarter ended September 30, 2022.

• IonOpticks ushers in a new age of proteomics with Aurora Frontier

  11/23/2022

  The field of proteomics is set to be revolutionised with the launch of IonOpticks' Aurora Frontier that achieves more than 10,000 proteins per sample.

• ICON plc to Present at the 2022 Evercore ISI HealthCONx Conference

  11/23/2022

  ICON plc, a world-leading healthcare intelligence and clinical research organisation, announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the 2022 Evercore ISI HealthCONx Conference on Wednesday, November 30, 2022.

• Omnicell to Present at the Piper Sandler 34th Annual Healthcare Conference

  11/23/2022

  Omnicell, Inc. announced its participation in the upcoming investor conference: Randall Lipps, Omnicell Chairman, President, Chief Executive Officer And Founder, and Peter Kuipers, Omnicell Executive Vice President, Chief Financial Officer, will present at the Piper Sandler 34th Annual Healthcare Conference on Wednesday, November 30, 2022 at 9:00 a.m. Eastern Time.

• The Native Antigen Company Strengthens Senior Team to Support Growing Product Portfolio

  11/23/2022

  The Native Antigen Company, one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, announced two key appointments to its management team.

• Top 10 Pharma Company Reduces Drug Wastage through Adoption of Calyx IRT Medication Pooling

  11/22/2022

  Calyx announced that a Top 10 pharmaceutical company is leveraging medication pooling, an advanced inventory management strategy available through Calyx IRT, to improve drug distribution efficiencies and reduce drug wastage in an ongoing, global clinical development program.

• Waters Introduces New PFAS Quantitation Workflow Enabled by Enhancements to waters_connect Informatics Platform

  11/22/2022

  Waters Corporation announced a new Per-and Polyfluoroalkyl Substances quantitation workflow enabled by enhancements to its waters_connect™ for quantitation software.

• Professors Anna Schwedenman¹ and Sarfaraz Niazi² awarded a $2 Million FDA grant to create novel analytical methods to reduce the cost of developing biosimilars

  11/22/2022

  To reduce the cost of development of the approval of biosimilars, the FDA is encouraging the introduction of novel analytical methods to establish biosimilarity, reducing more expensive and time-consuming testing.

• Median Technologies to Speak at the Radiological Society of North America (RSNA) 2022 Annual Meeting, Nov. 27 - Dec 1, Chicago, IL, USA, With Three Presentations

  11/22/2022

  Median Technologies announced that the Company will be speaking and presenting at the world’s largest medical imaging conference, the 2022 Radiological Society of North America Annual Meeting and Scientific Assembly, being held in Chicago, IL, USA, Nov. 27 – Dec. 1.

• Fujifilm Invests $188 Million in New Cell Culture Media Manufacturing Facility

  11/22/2022

  FUJIFILM Corporation announced a $188 million investment to establish a cell culture media manufacturing facility in Research Triangle Park, North Carolina, USA.

• Science 37 and BEKHealth Collaborate to Expand Patient Access Via Community Providers

  11/22/2022

  Science 37 Holdings, Inc., the industry-leading Metasite™, and BEKHealth, a leading clinical research platform, announced a partnership that will enable Science 37 to access the EMR data, exclusively, across its network of more than 35 thousand community providers, covering more than 35 million patient lives–expanding participant access, accelerating enrollment, and potentially reducing time to market for important investigational treatments and therapies.

• Clinical Evidence Shows Reduced Costs and Improved Outcomes in Heart Transplantation

  11/22/2022

  Paragonix Technologies, Inc., a leader in organ preservation technology and research, has announced the publication of a groundbreaking organ transplant study in the American Society for Artificial Internal Organs Journal.

• Amedisys Names Scott Ginn Acting Chief Operating Officer

  11/22/2022

  Amedisys, Inc., a leading provider of home health, hospice, personal care and high-acuity care, names Scott Ginn, Executive Vice President and Chief Financial Officer, its Acting Chief Operating Officer, effective immediately.

• Turbine Raises €20 Million in Series A Financing to Advance Programs & Partnerships Towards the Clinic with World’s First Cancer Cell Simulation Platform

  11/22/2022

  Turbine, a company developing a cell behavior simulation platform, announced the closing of a €20 million Series A financing round.

• Study Reports Similar Efficacy of Dynamic Digital Radiography of the Chest with Lung Ventilation Perfusion for Detection of Chronic Thromboembolic Pulmonary Hypertension

  11/22/2022

  Konica Minolta Healthcare Americas, Inc. is pleased to announce the publication of a study that found Dynamic Digital Radiography of the chest delivers similar efficacy as lung ventilation perfusion for the detection of chronic thromboembolic pulmonary hypertension.

• Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business

  11/22/2022

  Alcon, the global leader in eye care dedicated to helping people see brilliantly, announced that it has completed its acquisition of Aerie Pharmaceuticals, Inc.

• LeMaitre to Present at Upcoming Investor Conferences - November 22, 2022

  11/22/2022

  LeMaitre Vascular, Inc. announced that it is participating in two upcoming investor conferences.